— Know what they know.
Not Investment Advice

NDRA NASDAQ

ENDRA Life Sciences Inc.
1W: +0.3% 1M: -6.2% 3M: +26.5% YTD: +41.3% 1Y: +5.4% 3Y: -99.7% 5Y: -100.0%
$6.06
+0.18 (+3.06%)
 
Weekly Expected Move ±11.2%
$5 $5 $6 $7 $7
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 64 · $7.7M mcap · 1M float · 3.14% daily turnover · Short 36% of daily vol

Balance Sheet Trends

Total Assets
$4M -34.1% ▼
5Y CAGR: -9.1%
Total Liabilities
$2M +72.8% ▲
5Y CAGR: -4.8%
Shareholders Equity
$3M -54.8% ▼
5Y CAGR: -11.7%
Cash & Investments
$3M +14.0% ▲
5Y CAGR: -12.2%
Total Debt
$584K +48.2% ▲
5Y CAGR: -5.4%
Net Debt
-$3M -8.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$7M$9M$5M$3M$3M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$7M$9M$5M$3M$3M
Net Receivables$0$0$0$0$0
Inventory$590K$1M$3M$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$8M$12M$9M$3M$3M
Property, Plant & Equip.$551K$775K$741K$466K$647K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$6K$6K$6K$3M$371K
Total Non-Current Assets$557K$781K$747K$4M$1M
Total Assets$9M$13M$9M$7M$4M
— Liabilities —
Accounts Payable$403K$791K$614K$360K$270K
Short-Term Debt$84K$117K$28K$28K$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0-$0$159K$149K$170K
Total Current Liabilities$987K$2M$2M$903K$605K
Long-Term Debt$337K$28K$0$0$0
Other Non-Current Liab.$0$0$0$0$799K
Total Non-Current Liabilities$609K$547K$366K$192K$1M
Total Liabilities$2M$2M$2M$1M$2M
— Equity —
Common Stock$3K$212$317$1K$53
Retained Earnings-$57M-$69M-$82M-$92M-$103M
Accumulated OCI$11K$14K$6K$5K$0
Total Stockholders Equity$7M$11M$7M$6M$3M
Total Liabilities & Equity$9M$13M$9M$7M$4M
— Key Metrics —
Total Debt$769K$796K$547K$394K$584K
Net Debt-$6M-$9M-$4M-$2M-$3M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms